The organizations collectively known as the Quadripartite today released a set of recommendations and priorities to be considered at the upcoming United Nations (UN) High-level Meeting (HLM) on Antimicrobial Resistance (AMR).

The group, which comprises the World Health Organization, the World Organization for Animal Health, the UN Food and Agriculture Organization, and the UN Environment Programme, is the latest to make recommendations ahead of the September meeting, which will conclude with a political declaration that will guide global efforts to address AMR. The Quadripartite said that, while the 2016 UN HLM on AMR was a "landmark" in global commitment to tackle AMR, the progress made since then has been insufficient, and greater urgency is needed.

"The HLM on AMR presents a unique opportunity for global leaders to invest in the present and secure our future by enabling effective national and global actions to save millions of lives, safeguard animal health, food safety, food security, protect the environment, and fortify economies against the threats of AMR for years to come," the group said in its policy brief.

Key recommendations

In the brief, the Quadripartite makes five recommendations for UN member states to consider including in the political declaration. The first is to implement measures for effective sub-national, national, regional, and global governance, leadership, and organization. This should include updating the 2016 Global Action Plan on AMR, ensuring that national action plans on AMR include all relevant sectors and have an appropriate accountability framework, formally recognizing the Quadripartite Joint Secretariat as the central coordinating mechanism for the global One Health response to AMR, and creating an independent panel on evidence for action on AMR.

The document also calls on member states to allocate adequate, predictable, and sustainable financing for the AMR response; to commit to actionable targets and bolster monitoring and strategic information systems to guide and accelerate the AMR response; to prevent the emergence and spread of AMR through system-wide transformation across human, animal, plant, and environmental sectors; and to urgently address the crises surrounding research & development and access to effective medication, diagnostics, and other measures.

The HLM on AMR presents a unique opportunity for global leaders to invest in the present and secure our future by enabling effective national and global actions to save millions of lives, safeguard animal health, food safety, food security, protect the environment, and fortify economies against the threats of AMR for years to come.

Cuba's health ministry this week announced the detection of Oropouche virus cases in two cities in Santiago province in the southeastern part of the country.

In a statement, the ministry said the cases were found during surveillance for nonspecific fever syndromes in Santiago province. Cases were identified from the province's capital city Santiago and from Songo La Maya, about 16 miles to the northeast. The samples were confirmed at the national reference lab at the Pedro Kouri Institute.

Patients' conditions improved between the third and fourth day of symptom onset, and actions are underway to limit the spread of the disease, the ministry said.

5 Americas countries have now reported cases this year

The Pan American Health Organization (PAHO) has warned of rising Oropouche virus cases in some Americas countries, with cases this year reported from Brazil, Bolivia, Colombia, and Peru. In its most recent update, it urged countries to enhance their surveillance and clinical suspicion for Oropouche virus cases, given detections outside of Brazil's Amazonas region and widespread dengue circulation in many countries in the Americas region.

Oropouche virus is mainly spread by a species of biting midge called Culicoides paraensis but can also be transmitted by certain Culex mosquitoes. Symptoms are similar to dengue, including a sudden onset of fever, headache, musculoskeletal pain, chills, and sometimes, nausea. Some patients experience aseptic meningitis. Most patients recover in about a week, but for some, symptoms linger for weeks.